Basic Information
| LncRNA/CircRNA Name | uc.338 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR etc. |
| Sample | non small cell lung cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | We found that uc.338 expression levels were significantly upregulated in NSCLC compared with the matched noncancerous lung tissues. More importantly, Kaplan-Meier survival analysis demonstrated that higher uc.338 expression levels were associated with a shorter overall survival (P< 0.0016) and disease-free survival (p< 0.0001) in NSCLC patients. |
| Pubmed ID | 29843223 |
| Year | 2018 |
| Title | Up-regulation of long noncoding RNA uc.338 predicts poor survival in non-small cell lung cancer |
External Links
| Links for uc.338 | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |